drugset

drugset / Trial / NCT00736385

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00736385 ↗

Phase 4 Terminated 11 enrolled Duke University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to find out if Metformin is safe and useful in the treatment of NAFLD.

Timeline

Start: 2009-04
Primary completion: 2012-12
Completion: 2012-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Metformin	Small molecule	2000 mg	—

Indications